Financhill
Sell
35

NAMS Quote, Financials, Valuation and Earnings

Last price:
$24.96
Seasonality move :
25.49%
Day range:
$24.78 - $25.92
52-week range:
$15.19 - $27.29
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
66.90x
P/B ratio:
6.08x
Volume:
637.5K
Avg. volume:
1.1M
1-year change:
44.81%
Market cap:
$2.3B
Revenue:
$14.1M
EPS (TTM):
-$2.25

Earnings Data

Next earnings date for NAMS
Feb 28
2025
Most recent earnings per share
-$0.18
Beat by $0.31
(Nov 6/2024)
Consensus Estimate
-$0.49
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NAMS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $3.1M -- -- -$0.43 --
02/28/2025 Q4 $1.7M -- -- -$0.48 --
11/06/2024 Q3 $1.8M $29.1M -$0.18 -$0.49 $0.31
08/07/2024 Q2 $1.2M $2.3M -$0.41 -$0.57 $0.16
05/09/2024 Q1 $1.7M $1.4M -$1.06 -$0.52 -$0.54
02/28/2024 Q4 $1.9M $803K -$0.60 -$0.59 -$0.01
11/13/2023 Q3 -- -- -- -$0.52 --
08/07/2023 Q2 -- -- -$0.49 -$0.47 -$0.02
05/08/2023 Q1 -- -- -$0.51 -- --
12/31/2022 Q4 -- -- -- -$0.43 --
09/30/2022 Q3 -- -- -- -$0.59 --

NewAmsterdam Pharma Co NV Earnings Questions

  • How Much did NewAmsterdam Pharma Co NV Generate in Revenue Last Quarter?

    NewAmsterdam Pharma Co NV reported $29.1M worth of top line sales in its most recent quarter.

  • Did NewAmsterdam Pharma Co NV Beat Earnings Last Quarter?

    NewAmsterdam Pharma Co NV announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.49 per share.

  • Is NewAmsterdam Pharma Co NV Profitable?

    NewAmsterdam Pharma Co NV reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for NewAmsterdam Pharma Co NV EPS Next Year?

    NewAmsterdam Pharma Co NV's earnings are forecast to decrease from -$2.15 per share to -$2.08 per share next year representing a decrease of -2.34%.

  • When is NewAmsterdam Pharma Co NV's Earnings Date?

    NewAmsterdam Pharma Co NV's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock Overvalued?
Is Broadcom Stock Overvalued?

The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…

4 Top Dividend Stocks to Buy Now
4 Top Dividend Stocks to Buy Now

If you’re looking for steady income, dividend stocks are a…

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 39x

Sell
47
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 114x

Sell
39
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
87
CEG alert for Jan 11

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
1
MCY alert for Jan 11

Mercury General [MCY] is down 19.87% over the past day.

Buy
84
ATZAF alert for Jan 11

Aritzia [ATZAF] is up 17.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock